138 related articles for article (PubMed ID: 27181575)
21. 2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase.
Jonckers TH; Lin TI; Buyck C; Lachau-Durand S; Vandyck K; Van Hoof S; Vandekerckhove LA; Hu L; Berke JM; Vijgen L; Dillen LL; Cummings MD; de Kock H; Nilsson M; Sund C; Rydegård C; Samuelsson B; Rosenquist A; Fanning G; Van Emelen K; Simmen K; Raboisson P
J Med Chem; 2010 Nov; 53(22):8150-60. PubMed ID: 21033671
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine.
Lam AM; Espiritu C; Murakami E; Zennou V; Bansal S; Micolochick Steuer HM; Niu C; Keilman M; Bao H; Bourne N; Veselenak RL; Reddy PG; Chang W; Du J; Nagarathnam D; Sofia MJ; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2011 Jun; 55(6):2566-75. PubMed ID: 21444700
[TBL] [Abstract][Full Text] [Related]
23. 2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938.
Reddy PG; Bao D; Chang W; Chun BK; Du J; Nagarathnam D; Rachakonda S; Ross BS; Zhang HR; Bansal S; Espiritu CL; Keilman M; Lam AM; Niu C; Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2010 Dec; 20(24):7376-80. PubMed ID: 21050754
[TBL] [Abstract][Full Text] [Related]
24. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of
Wang G; Dyatkina N; Prhavc M; Williams C; Serebryany V; Hu Y; Huang Y; Wu X; Chen T; Huang W; Rajwanshi VK; Deval J; Fung A; Jin Z; Stoycheva A; Shaw K; Gupta K; Tam Y; Jekle A; Smith DB; Beigelman L
J Med Chem; 2020 Sep; 63(18):10380-10395. PubMed ID: 32816483
[TBL] [Abstract][Full Text] [Related]
27. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
28. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
29. In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor.
Voitenleitner C; Crosby R; Walker J; Remlinger K; Vamathevan J; Wang A; You S; Johnson J; Woldu E; Van Horn S; Horton J; Creech K; Shotwell JB; Hong Z; Hamatake R
Antimicrob Agents Chemother; 2013 Nov; 57(11):5216-24. PubMed ID: 23939896
[TBL] [Abstract][Full Text] [Related]
30. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
[TBL] [Abstract][Full Text] [Related]
31. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
32. Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development.
Nair AG; Zeng Q; Selyutin O; Rosenblum SB; Jiang Y; Yang DY; Keertikar K; Zhou G; Dwyer MP; Kim SH; Shankar B; Yu W; Tong L; Chen L; Mazzola R; Caldwell J; Tang H; Allard ML; Buckle RN; Gauuan PJ; Holst CL; Martin GS; Naicker KP; Vellekoop S; Agrawal S; Liu R; Kong R; Ingravallo P; Xia E; Zhai Y; Nomeir A; Kozlowski JA
Bioorg Med Chem Lett; 2016 Mar; 26(5):1475-9. PubMed ID: 26850003
[TBL] [Abstract][Full Text] [Related]
33. Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity.
Yu W; Coburn CA; Yang DY; Meinke PT; Wong M; Rosenblum SB; Chen KX; Njoroge GF; Chen L; Dwyer MP; Jiang Y; Nair AG; Selyutin O; Tong L; Zeng Q; Zhong B; Ji T; Hu B; Agrawal S; Xia E; Zhai Y; Liu R; Kong R; Ingravallo P; Asante-Appiah E; Nomeir A; Fells J; Kozlowski JA
Bioorg Med Chem Lett; 2016 Jul; 26(13):3158-3162. PubMed ID: 27180013
[TBL] [Abstract][Full Text] [Related]
34. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256.
Yang H; Yang C; Wang Y; Rhodes G; Robinson M; Cheng G; Qi X; Mo H; Tian Y; Pakdaman R; Sheng XC; Kim CU; Delaney WE
Antivir Ther; 2017; 22(5):413-420. PubMed ID: 28106531
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymerase.
Berke JM; Vijgen L; Lachau-Durand S; Powdrill MH; Rawe S; Sjuvarsson E; Eriksson S; Götte M; Fransen E; Dehertogh P; Van den Eynde C; Leclercq L; Jonckers TH; Raboisson P; Nilsson M; Samuelsson B; Rosenquist Å; Fanning GC; Lin TI
Antimicrob Agents Chemother; 2011 Aug; 55(8):3812-20. PubMed ID: 21576430
[TBL] [Abstract][Full Text] [Related]
36. Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency.
Cheng Y; Shen J; Peng RZ; Wang GF; Zuo JP; Long YQ
Bioorg Med Chem Lett; 2016 Jun; 26(12):2900-2906. PubMed ID: 27133482
[TBL] [Abstract][Full Text] [Related]
37. Discovery of potent macrocyclic HCV NS5A inhibitors.
Yu W; Vibulbhan B; Rosenblum SB; Martin GS; Vellekoop AS; Holst CL; Coburn CA; Wong M; Selyutin O; Ji T; Zhong B; Hu B; Chen L; Dwyer MP; Jiang Y; Nair AG; Tong L; Zeng Q; Agrawal S; Carr D; Rokosz L; Liu R; Curry S; McMonagle P; Ingravallo P; Lahser F; Asante-Appiah E; Fells J; Kozlowski JA
Bioorg Med Chem Lett; 2016 Aug; 26(15):3793-9. PubMed ID: 27282743
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
[TBL] [Abstract][Full Text] [Related]
39. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
[TBL] [Abstract][Full Text] [Related]
40. 3'-Deoxy phosphoramidate dinucleosides as improved inhibitors of hepatitis C virus subgenomic replicon and NS5B polymerase activity.
Priet S; Zlatev I; Barvik I; Geerts K; Leyssen P; Neyts J; Dutartre H; Canard B; Vasseur JJ; Morvan F; Alvarez K
J Med Chem; 2010 Sep; 53(18):6608-17. PubMed ID: 20799693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
